Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients’ sera
Marten Beeg, Cesare Burti, Eleonora Allocati, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 14

Showing 14 citing articles:

Innovative FO-SPR Label-free Strategy for Detecting Anti-RBD Antibodies in COVID-19 Patient Serum and Whole Blood
Jia-Huan Qu, Karen Leirs, Wim Maes, et al.
ACS Sensors (2022) Vol. 7, Iss. 2, pp. 477-487
Open Access | Times Cited: 43
Switching Among Biosimilars: A Review of Clinical Evidence
Eleonora Allocati, Brian Godman, Marco Gobbi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30
A deeper evaluation of cytokeratin fragment 21-1 as a lung cancer tumor marker and comparison of different assays
Dianna J. Rowe, T. Khalil, Michael N. Kammer, et al.
Biosensors and Bioelectronics X (2025), pp. 100593-100593
Open Access
The first WHO reference panel for Infliximab anti-drug antibodies: a step towards harmonizing therapeutic drug monitoring
Meenu Wadhwa, Isabelle Cludts, Eleanor Atkinson, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Artificial Intelligence-Powered Molecular Docking and Steered Molecular Dynamics for Accurate scFv Selection of Anti-CD30 Chimeric Antigen Receptors
Nico Martarelli, Michela Capurro, G. Mansour, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7231-7231
Open Access | Times Cited: 4
Approaches for the detection and analysis of antidrug antibodies to biopharmaceuticals: A review
Kyungah Suh, Isaac Kyei, David S. Hage
Journal of Separation Science (2022) Vol. 45, Iss. 12, pp. 2077-2092
Open Access | Times Cited: 18
Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapies
Zelin Feng, Guangbo Kang, Jiewen Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114174-114174
Open Access | Times Cited: 15
Kinetic study of membrane protein interactions: from three to two dimensions
Vladimir Adrien, Myriam Reffay, Nicolas Taulier, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Development of a Bispecific IgG1 Antibody Targeting BCMA and PDL1
Irene Cattaneo, Sylvie Choblet, Rut Valgardsdottir, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 15-15
Open Access | Times Cited: 1
Surface plasmon resonance assays for the therapeutic drug monitoring of infliximab indicate clinical relevance of anti-infliximab antibody binding properties
Melina K. Grasmeier, Susanne Weber, Matthias Treiber, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 7, pp. 1255-1265
Open Access | Times Cited: 3
Validation of plasmonic-based biosensors for rapid and sensitive detection of rabbit hemorrhagic and foot-and-mouth disease viruses in biological samples
Chiara Urbinati, Vittoria Di Giovanni, Giulia Pezzoni, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial Insights
Sophie O’Reilly, Joanne Byrne, Eoin R. Feeney, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1089-1089
Open Access
Validation of plasmonic-based biosensors for rapid and in depth characterization of monoclonal antibodies directed against rabbit haemorrhagic and foot-and-mouth disease viruses in biological samples
Chiara Urbinati, Giulia Pezzoni, Patrizia Cavadini, et al.
Methods (2024) Vol. 234, pp. 85-92
Closed Access
Evaluating the Performance of Two Automated Anti-drug Antibodies Assays for Infliximab and Adalimumab Without Acid Dissociation
Carley Karsten, Karin Grannas, Oskar Bergman, et al.
The AAPS Journal (2024) Vol. 26, Iss. 5
Open Access
Quantitative evaluation of adalimumab and anti-adalimumab antibodies in sera using a surface plasmon resonance biosensor
Andrea Di Santo, Matteo Accinno, Fosca Errante, et al.
Clinical Biochemistry (2024) Vol. 133-134, pp. 110838-110838
Closed Access
Page 1

Scroll to top